Genetech enlightens other angiogenesis programs.
Brower
V
V
D002318:Cardiovascular Diseases / Q000628:therapy*; D002986:Clinical Trials as Topic; D016228:Endothelial Growth Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D015316:Genetic Therapy; D006133:Growth Substances / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008222:Lymphokines / Q000008:administration & dosage / Q000627:therapeutic use*; D018919:Neovascularization, Physiologic; D011994:Recombinant Proteins / Q000627:therapeutic use; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D006133:Growth Substances; D008222:Lymphokines; D011994:Recombinant Proteins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors